-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

508. Bone Marrow Failure: Acquired: Poster III Clinically Relevant Abstract

Symposia: Bone Marrow Failure: Acquired Program: Oral and Poster Abstracts
Type: Poster
Monday, December 11, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Orianne Wagner-Ballon, MD, PhD1, Anna Raimbault, PharmD, PhD2*, Camille Debord, PharmD3*, Valérie Soenen, MD, PhD4*, Anne-Catherine Lhoumeau, PharmD, PhD5*, Jean-Philippe Vial, MD6*, Veronique Harrivel, MD7*, Juliette Vo Xuan, PharmD8*, Marie Loosveld, MD, PhD9*, Gerard Socié10, Regis Peffault De Latour11*, Ekbel Amri12*, Manuelle Rongy, PhD, MSc12*, Bernard Drenou, MD13*, Agathe Debliquis, PharmD14* and Magali Le Garff-Tavernier15*

1Hematology and Immunology Department, Henri Mondor University Hospital, UPEC, Assistance Publique Hopitaux de Paris, Creteil, FRA
2Service d’Hématologie Biologique, APHP Hôpital Saint Louis, Paris, France
3Nantes University Hospital, Nantes, FRA
4Laboratoire d’Hématologie, CRHU Lille, Lille, France
5Department of Biopathology, Institut Paoli-Calmettes, Marseille, France
6CHU Bordeaux, PESSAC, France
7Hematology Laboratory, Centre hospitalier universitaire d'Amiens, Amiens, FRA
8Hematology and Immunology Department, Henri Mondor University Hospital, UPEC, Assistance Publique Hopitaux de Paris, Créteil, France
9Hematology Laboratory, Marseille, FRA
10Hopital St. Louis, Department of Hematology - BMT, Paris, France
11BMT Unit, Assistance Publique Hôpitaux de Paris, Université Paris Cité, Paris, France
12Alexion Pharma France, Paris, France
13Service d'Hématologie, Groupe Hospitalier de la Région Mulhouse Sud Alsace, Mulhouse, France
14Laboratoire d’Hématologie, Groupe Hospitalier de la Région Mulhouse Sud Alsace, Mulhouse, France
15Hematology Laboratory, Assistance Publique-Hôpitaux de Paris, Pitie-Salpetriere Hospital, Paris, France

Antonio M Risitano, MD, PhD1,2, Bing Han, MD, PhD3*, Austin Kulasekararaj, MD, MBBS, FRCPath, MRCP4,5,6, Yasutaka Ueda7*, Phillip Scheinberg, MD8, Carlos de Castro9*, Jaroslaw P. Maciejewski, M.D., Ph.D., FACP10, Josefin Snellman11*, Ranjan Tiwari12*, Marion Dahlke, MD, MSc13* and Régis Peffault de Latour14,15*

1AORN Moscati, Avellino, Italy
2University of Naples Federico II, Naples, Italy
3Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China
4King’s College Hospital NHS, London, United Kingdom
5National Institute for Health and Care Research and Wellcome King’s Research Facility, London, United Kingdom
6King’s College London, London, United Kingdom
7Osaka University Graduate School of Medicine, Suita, Japan
8Hospital A Beneficência Portuguesa, São Paulo, Brazil
9Duke University School of Medicine, Durham, NC
10Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
11Novartis Pharma AG, Basel, Switzerland
12Novartis Healthcare Pvt. Ltd, Hyderabad, India
13Novartis, Basel, Switzerland
14French Reference Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Paris, France
15Assistance Publique Hôpitaux de Paris, Université Paris Cité, Paris, France

Hiroki Mizumaki, MD, PhD1*, Shouguo Gao, PhD1*, Zhijie Wu, MD PhD1*, Emma M. Groarke, MD2, Lemlem Alemu1*, Diego Quinones Raffo3*, Olga Rios1*, Sachiko Kajigaya, PhD1*, Bhavisha A. Patel, MD1 and Neal S. Young, MD1

1Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
2Hematology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD
3National Heart, Lung, and Blood Institute (NHLBI)/NIH, Bethesda, MD

Huihui Fan1*, Jing Hu2*, Wenrui Yang1*, Xin Zhao1, Li Zhang1*, Kang Zhou1*, Youzhen Xiong1*, Liping Jing, MD3* and Fengkui Zhang4*

1Anemia Therapeutic Center, Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin, China
2Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin, China,, Tianjin, China
3Anemia Therapeutic Center, Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin, AL, China
4State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Anemia Therapeutic Center, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Xin Zhao, md1, Jianping Li2*, Huihui Fan2*, Liping Jing, MD3*, Li Zhang2*, Kang Zhou2*, Wenrui Yang2*, Yuan Li2*, Yang Yang2*, Lei Ye, MD2*, Guangxin Peng2*, Youzhen Xiong2*, Jun Shi4* and Fengkui Zhang2*

1Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2Anemia Therapeutic Center, Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin, China
3Anemia Therapeutic Center, Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin, AL, China
4Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Pontus Lundberg1*, Silvia de la Iglesia, MD, PhD2*, Richard J Kelly, PhD3*, Austin Kulasekararaj, MD, MBBS, FRCPath, MRCP4,5,6, Jun-Ichi Nishimura, MD, PhD7, Antonio M Risitano, MD, PhD8, Alexander Röth, MD9, Simon Buatois10*, Sammy Chebon10*, Himika Patel, PharmD11* and Anna Kiialainen10*

1F. Hoffmann-La Roche Ltd., Basel, Switzerland
2Hematology Department, University Hospital of Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
3Department of Haematology, St James's University Hospital, Leeds, United Kingdom
4Department of Haematological Medicine, King's College Hospital, London, United Kingdom
5National Institute for Health Research and Wellcome King's Clinical Research Facility, London, United Kingdom
6King’s College London, London, United Kingdom
7Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan
8Hematology and BMT Unit, AORN San Giuseppe Moscati, Avellino, Italy
9Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany
10F. Hoffmann-La Roche Ltd, Basel, Switzerland
11Genentech, Inc., San Fransisco, CA

Michihiro Hashimoto, PhD1,2*, Jue Li3*, Paul R. Andreassen, PhD3* and Gang Huang, PhD1,2

1Department of Cell Systems and Anatomy, UT Health San Antonio, San Antonio, TX
2Department of Pathology and Laboratory Medicine, UT Health San Antonio, San Antonio, TX
3Cincinnati Children's Hosp. Med. Ctr., Cincinnati, OH

Jens Panse, MD1,2, Jaroslav Cermak3, Olena Kyselova, MD, PhD4*, Akihiko Gotoh, MD, PhD5, Fahri Sahin6*, Hubert Schrezenmeier, MD7,8, Alice C. Chang9*, Brittany Gentile, PhD10*, Marianne Uguen11* and Bing Han12*

1Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany
2Center of Integrated Oncology (CIO), Aachen, Bonn, Cologne, Düsseldorf (ABCD), Germany
3Institute of Hematology and Blood Transfusion, Prague, Czech Republic
4Institute of Hematology and Transfusiology, National Academy of Medical Science, Kiev, Ukraine, Kiev, Ukraine
5Department of Hematology, Tokyo Medical University, Tokyo, JPN
6Division of Hematology, Department of Internal Medicine,, Ege University, Izmir, Turkey
7University of Ulm, Ulm, Germany
8German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm, Ulm, Germany
9Genentech Inc., South San Francisco, CA, SUNNYVALE, CA
10Genentech, Inc., South San Francisco, CA, San Francisco, CA
11F. Hoffman-La Roche, Basel, Switzerland
12Department of Hematology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, CHN

Wenrui Yang*, Xin Zhao, Youzhen Xiong*, Huihui Fan*, Jianping Li*, Lei Ye, MD*, Li Zhang*, Liping Jing, MD* and Fengkui Zhang*

Anemia Therapeutic Center, Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin, China

Austin Kulasekararaj, MD, MBBS, FRCPath, MRCP1, Francesco Lanza, MD2*, Alexandros Arvanitakis3*, Saskia MC Langemeijer, MD, PhD4*, Satheesh Chonat, MD5, Jia Cao6*, Vincent Chow6* and Haby Henary6*

1Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, ENG, United Kingdom
2Hematology Unit and Metropolitan Romagna Transplant Network, University of Bologna, Ravenna, Italy
3Skånes Universitetssjukhus Malmö, Malmö, Sweden
4Department of Hematology, Radboud university medical center, Nijmegen, Netherlands
5Emory University and Children's Healthcare of Atlanta, Atlanta, GA
6Amgen Inc., Thousand Oaks, CA

Ahmet Celal Toprak, B.S.1*, Taha Bat, MD2, Mutlu Mete, Ph.D.3*, Carmelo Gurnari, MD4, Zoe Bass, B.S.A.1*, Jaroslaw P. Maciejewski, M.D., Ph.D., FACP4, Hussein Awada4*, Alper Olcal, M.D.2* and Ibrahim F. Ibrahim, M.D.5

1University of Texas Southwestern Medical Center, Dallas, TX
2Department of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX
3Department of Computer Science and Information Systems, Texas A&M University - Commerce, Commerce, TX
4Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
5Department of Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX

Anthony DeLise1*, Natasa Zamurovic2*, Regine Hansen3*, Thierry Flandre4*, Robert Schmouder5* and Chiara Buono6*

1Novartis Institutes of Biomedical Research, Preclinical Safety, East Hanover, NJ
2Novartis Institutes For Biomedical Research, Basel, Switzerland
3Novartis Pharma AG, Preclinical Safety, Basel, Switzerland
4Novartis Institutes for Biomedical Research, Basel, Switzerland
5Novartis Pharmaceuticals Corporation, East Hanover, NJ
6Novartis Institutes for Biomedical Research, Cambridge, MA

Mark Orland, MD1, Yasuo Kubota, MD, PhD2*, Danai Dima, MD1, Carlos Bravo-Perez, MD, PhD1*, Luca Guarnera, MD1*, Carmelo Gurnari, MD1*, Jaroslaw P. Maciejewski, M.D., Ph.D., FACP1 and Valeria Visconte, PhD1

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Beachwood, OH

Robert Schmouder1*, Guido Junge, MD, PhD2*, Prasanna Kumar Nidamarthy3* and Kenneth Kulmatycki4*

1Novartis Pharmaceuticals Corporation, East Hanover, NJ
2Novartis Institutes of Biomedical Research, Basel, Switzerland
3Novartis Healthcare Pvt. Ltd., Hyderabad, India
4Novartis Institutes of Biomedical Research, Cambridge, MA

Alexandra Pike, MBBS, FRCPath, MRCP1*, Stephen John Richards, PhD, FRCPath2*, Claire E McKinley, BSc2*, Louise M Arnold, BSc (hons)3*, Abraham Mullasseril Varghese, MBBS, MRCP4*, Talha Munir, MBBS, MRCP, FRCPath, PhD3*, Petra Muus, MD5, Peter Hillmen, MB ChB, PhD6, Morag Griffin, FRCPath, MRCP5*, Richard J Kelly, PhD5* and Darren Newton, PhD7*

1Leeds Institute of Medical Research, University of Leeds, Wakefield, ENG, United Kingdom
2Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom
3Department of Haematology, St. James's University Hospital, Leeds, United Kingdom
4Department of Haematology, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
5Department of Haematology, St James's University Hospital, Leeds, United Kingdom
6Leeds Institute of Medical Research, St. James's University Hospital, Leeds, United Kingdom
7Leeds Institute of Medical Research, University of Leeds, Leeds, ENG, United Kingdom

Sung-Eun Lee, MD1*, Gi-June Min2*, Sung-Soo Park, MD3*, Silvia Park4*, Jae-Ho Yoon, MD2, Byoung-Sik Cho3*, Ki-Seong Eom2*, Yoo-Jin Kim2, Seok Lee2, Chang-Ki Min2*, Heeje Kim, MD, PhD3, Seok-Goo Cho2* and Jong-Wook Lee, MD5

1Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Houston, TX
2Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
3Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
4Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, AL, South Korea
5Department of Hematology, Seoul St. Mary's Hospital Catholic University of Korea, Seoul, South Korea

*signifies non-member of ASH